Systemic Inflammatory Response Syndrome Is a Major Contributor to COVID-19-Associated Coagulopathy: Insights From a Prospective, Single-Center Cohort Study.
作者信息
Masi Paul, Hékimian Guillaume, Lejeune Manon, Chommeloux Juliette, Desnos Cyrielle, Pineton De Chambrun Marc, Martin-Toutain Isabelle, Nieszkowska Ania, Lebreton Guillaume, Bréchot Nicolas, Schmidt Matthieu, Edouard Luyt Charles, Combes Alain, Frere Corinne
机构信息
Medical Intensive Care Unit (P.M., G.H., J.C., C.D., M.P.D.C., A.N., N.B., M.S., C.E.L., A.C.), Department of Hematology (M.L., I.M.-T., C.F.), and Cardiothoracic Surgery Department (G.L.), Assistance Publique-Hôpitaux de Paris, Pitié-Salpêtrière Hospital, France. Sorbonne Université, INSERM UMRS_1166, Institute of Cardiometabolism and Nutrition, Paris, France (G.H., G.L., M.S., C.E.L., A.C., C.F.).
出版信息
Circulation. 2020 Aug 11;142(6):611-614. doi: 10.1161/CIRCULATIONAHA.120.048925. Epub 2020 Jun 17.
Abstract
摘要
相似文献
1
Systemic Inflammatory Response Syndrome Is a Major Contributor to COVID-19-Associated Coagulopathy: Insights From a Prospective, Single-Center Cohort Study.全身炎症反应综合征是新冠病毒相关凝血病的主要促成因素：一项前瞻性单中心队列研究的见解
Circulation. 2020 Aug 11;142(6):611-614. doi: 10.1161/CIRCULATIONAHA.120.048925. Epub 2020 Jun 17.
2
Insights into pediatric multi-system inflammatory syndrome and COVID-19.儿童多系统炎症综合征与新型冠状病毒肺炎的见解
Clin Chim Acta. 2020 Nov;510:121-122. doi: 10.1016/j.cca.2020.07.025. Epub 2020 Jul 14.
3
The unique characteristics of COVID-19 coagulopathy.COVID-19 凝血功能障碍的独特特征。
Crit Care. 2020 Jun 18;24(1):360. doi: 10.1186/s13054-020-03077-0.
4
ISTH interim guidance on recognition and management of coagulopathy in COVID-19.国际血栓与止血学会（ISTH）关于新冠病毒病（COVID-19）凝血病识别与管理的临时指南。
J Thromb Haemost. 2020 May;18(5):1023-1026. doi: 10.1111/jth.14810. Epub 2020 Apr 27.
5
Inference from longitudinal laboratory tests characterizes temporal evolution of COVID-19-associated coagulopathy (CAC).从纵向实验室检测推断 COVID-19 相关凝血障碍 (CAC) 的时间演变。
Elife. 2020 Aug 17;9:e59209. doi: 10.7554/eLife.59209.
6
[Coagulopathy and COVID-19. Recommendations for a changing reality].[凝血功能障碍与2019冠状病毒病。应对不断变化的现实的建议]
Medicina (B Aires). 2020;80(5):505-511.
7
[Dealing with COVID-19-associated coagulopathy].[应对新型冠状病毒肺炎相关凝血病]
Ned Tijdschr Geneeskd. 2020 Apr 15;164:D5031.
8
COVID-19 and coagulative axis: review of emerging aspects in a novel disease.新型冠状病毒肺炎与凝血轴：一种新型疾病的新进展综述
Monaldi Arch Chest Dis. 2020 May 19;90(2). doi: 10.4081/monaldi.2020.1300.
9
Characteristics of Pediatric Inflammatory Multisystem Syndrome Associated with COVID-19.与新型冠状病毒肺炎相关的儿童炎症性多系统综合征的特征
Am J Nurs. 2020 Nov;120(11):1. doi: 10.1097/01.NAJ.0000721968.57773.b2.
10
A perfect storm: Root cause analysis of supra-therapeutic anticoagulation with vitamin K antagonists during the COVID-19 pandemic.一场完美风暴：COVID-19大流行期间维生素K拮抗剂超治疗性抗凝的根本原因分析
Thromb Res. 2020 Aug;192:73-74. doi: 10.1016/j.thromres.2020.05.024. Epub 2020 May 16.
引用本文的文献
1
Coagulation and inflammatory markers independently predict in-hospital mortality in aspiration pneumonia patients undergoing bronchoalveolar lavage.凝血和炎症标志物可独立预测接受支气管肺泡灌洗的吸入性肺炎患者的院内死亡率。
Am J Transl Res. 2025 Jun 15;17(6):4601-4611. doi: 10.62347/BAQD6951. eCollection 2025.
2
Heterogeneity of the Immunological and Pathogenic Profiles in Patients Hospitalize Early Versus Late During an Acute Vital Illness as Shown in Native SARS-CoV-2 Infection.新型严重急性呼吸综合征冠状病毒2型感染中，急性重症疾病早期与晚期住院患者免疫和致病特征的异质性。
Int J Mol Sci. 2025 Mar 6;26(5):2349. doi: 10.3390/ijms26052349.
3
Viscoelastic Study of Hemostasis Disorders Associated with Envenoming in North Benin Using a Quantra Analyzer.使用Quantra分析仪对贝宁北部与中毒相关的止血障碍进行粘弹性研究。
Toxins (Basel). 2024 Dec 24;17(1):3. doi: 10.3390/toxins17010003.
4
COVID-19 in the Initiation and Progression of Atherosclerosis: Pathophysiology During and Beyond the Acute Phase.新冠病毒感染在动脉粥样硬化的起始和进展中的作用：急性期及之后的病理生理学
JACC Adv. 2024 Jul 17;3(8):101107. doi: 10.1016/j.jacadv.2024.101107. eCollection 2024 Aug.
5
Immediate Clinical Complications Occurring During Membrane Change in Patients on Veno-Venous Extracorporeal Membrane Oxygenation.静脉-静脉体外膜肺氧合患者换膜期间发生的即时临床并发症
ASAIO J. 2025 Feb 1;71(2):120-127. doi: 10.1097/MAT.0000000000002270. Epub 2024 Jul 25.
6
COVID-19, Possible Hepatic Pathways and Alcohol Abuse-What Do We Know up to 2023?2023 年关于 COVID-19、可能的肝脏途径和酒精滥用，我们了解多少？
Int J Mol Sci. 2024 Feb 12;25(4):2212. doi: 10.3390/ijms25042212.
7
Mechanisms of endothelial activation, hypercoagulation and thrombosis in COVID-19: a link with diabetes mellitus.新型冠状病毒肺炎中血管内皮激活、高凝和血栓形成的机制：与糖尿病的关联。
Cardiovasc Diabetol. 2024 Feb 20;23(1):75. doi: 10.1186/s12933-023-02097-8.
8
Proinflammatory cytokines driving cardiotoxicity in COVID-19.促炎细胞因子在新型冠状病毒肺炎中引发心脏毒性。
Cardiovasc Res. 2024 Mar 13;120(2):174-187. doi: 10.1093/cvr/cvad174.
9
Non-bacterial thrombotic endocarditis in a patient with COVID.COVID 患者的非细菌性血栓性心内膜炎。
BMJ Case Rep. 2023 Oct 21;16(10):e256264. doi: 10.1136/bcr-2023-256264.
10
Comparison of the Efficacy and Safety Profiles of Different P2Y12 Inhibitors in Patients With ST-Segment Elevation Myocardial Infarction in the COVID-19 Era.新冠疫情时代不同P2Y12抑制剂在ST段抬高型心肌梗死患者中的疗效与安全性比较
Cureus. 2023 Aug 20;15(8):e43829. doi: 10.7759/cureus.43829. eCollection 2023 Aug.
本文引用的文献
1
Understanding pathophysiology of hemostasis disorders in critically ill patients with COVID-19.了解新冠肺炎危重症患者止血障碍的病理生理学。
Intensive Care Med. 2020 Aug;46(8):1603-1606. doi: 10.1007/s00134-020-06088-1. Epub 2020 May 15.
2
High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study.严重严重急性呼吸综合征冠状病毒 2 型感染患者的血栓形成风险高：一项多中心前瞻性队列研究。
Intensive Care Med. 2020 Jun;46(6):1089-1098. doi: 10.1007/s00134-020-06062-x. Epub 2020 May 4.
3
COVID-19 and its implications for thrombosis and anticoagulation.新型冠状病毒肺炎及其对血栓形成和抗凝的影响。
Blood. 2020 Jun 4;135(23):2033-2040. doi: 10.1182/blood.2020006000.
4
Pulmonary Embolism in Patients With COVID-19: Awareness of an Increased Prevalence.2019冠状病毒病患者的肺栓塞：对患病率增加的认识
Circulation. 2020 Jul 14;142(2):184-186. doi: 10.1161/CIRCULATIONAHA.120.047430. Epub 2020 Apr 24.
5
Thromboinflammation: challenges of therapeutically targeting coagulation and other host defense mechanisms.血栓炎症：治疗性靶向凝血和其他宿主防御机制的挑战。
Blood. 2019 Feb 28;133(9):906-918. doi: 10.1182/blood-2018-11-882993. Epub 2019 Jan 14.
Zotero 插件